Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
On May 4, a slick, 26-minute video was released, alleging that the coronavirus was actually a laboratory-manipulated virus deployed to wreak havoc so that a resulting vaccine could be used for profit. None of that was true, and Plandemic’s claims were thoroughly, repeatedly debunked.
Still, it went viral, getting liked on Facebook 2.5 million times. Soon after, another conspiracy theory took hold: Bill Gates's plan was to control vaccination efforts that would include tracking people via implanted microchips activated by 5G cellular towers. Again, obviously not true.
But a Pew Research Center survey of US adults found that 36% thought these conspiracy theories were probably or definitely true. Perhaps some of those people are your family, your friends, your neighbors.
So how do you talk to a person who believes a conspiracy theory? This is something that the members of one of the internet’s most vibrant communities, r/ChangeMyView, deal with on a daily basis. This is the place on Reddit where people go to have their own beliefs challenged, and it is known as a calm, moderate place for debate.
We asked some of its most active users, as well as some conspiracy theory researchers, for their tips.
Androgen-Deprivation Therapies for Prostate Cancer and Risk Of Infection by SARS-CoV-2
HIGHLIGHTS
· SARS-CoV-2 infected men have a worse clinical outcome than women
· Cancer patients have an increased risk of SARS-CoV-2 infection
· Prostate cancer patients receiving androgen-deprivation therapies appear to be partially protected from the infection
Background Cell entry of SARS-CoV-2 depends on binding of the viral spike (S) proteins to ACE2 and on S protein priming by TMPRSS2. Inhibition of TMPRSS2 may work to block or decrease the severity of SARS-CoV-2 infections. Intriguingly, TMPRSS2 is an androgen-regulated gene that is upregulated in prostate cancer where it supports tumor progression and is involved in a frequent genetic translocation with the ERG gene.
First- or second-generation androgen-deprivation therapies (ADTs) decrease the levels of TMPRSS2. Here we put forward the hypothesis that ADTs may protect patients affected by prostate cancer from SARS-CoV-2 infections.
Materials and methods We extracted data regarding 9280 patients (4532 males) with laboratory-confirmed SARS-CoV-2 infection from 68 hospitals in Veneto, one of the Italian regions that was most affected by the COVID-19 pandemic. The parameters used for each COVID-19 positive patient were gender, hospitalization, admission to intensive care unit (ICU), death, tumor diagnosis, prostate cancer diagnosis, and androgen-deprivation therapy (ADT).
Results There were 9280 SARS-CoV-2 positive patients in the Veneto on April 1, 2020. Overall, males developed more severe complications, were more frequently hospitalized, and had a worse clinical outcome than females. Considering only the Veneto male population (2.4 Million men), 0.2% and 0.3% of non-cancer and cancer patients, respectively, tested positive for SARS-CoV-2.
Comparing the total number of SARS-CoV-2 positive cases, prostate cancer patients receiving ADT had a significantly lower risk of SARS-CoV-2 infection compared to patients who did not receive ADT (OR 4.05; 95% CI 1.55-10.59). A greater difference was found comparing prostate cancer patients receiving ADT to patients with any other type of cancer (OR 5.17; 95% CI 2.02-13.40).
Conclusion Our data suggest that cancer patients have an increased risk of SARS-CoV-2 infections than non-cancer patients. However, prostate cancer patients receiving ADT appear to be partially protected from SARS-CoV-2 infections.
Montopoli M, Zumerle S, Vettor R, et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532). Annals of Oncology 2020. http://www.sciencedirect.com/science/article/pii/S0923753420397970